Leukemia Plasma

In Stock Samples

Lot Number Condition Volume Race/Ethnicity Gender Country of Collection Medications Vials Price Action
78961 Leukemia 1.0 ML Male
Clopidogrel, Rituximab, Cyclophosphamide, Vincristine
1 $667.00
78962 Leukemia 1.0 ML Male
Clopidogrel, Rituximab, Cyclophosphamide, Vincristine
1 $667.00
78963 Leukemia 1.0 ML Male
Clopidogrel, Rituximab, Cyclophosphamide, Vincristine
1 $667.00
78964 Leukemia 1.0 ML Male
Clopidogrel, Rituximab, Cyclophosphamide, Vincristine
1 $667.00
78965 Leukemia 1.0 ML Male
Clopidogrel, Rituximab, Cyclophosphamide, Vincristine
1 $667.00
78966 Leukemia 1.0 ML Male
Clopidogrel, Rituximab, Cyclophosphamide, Vincristine
1 $667.00
78967 Leukemia 1.0 ML Male
Clopidogrel, Rituximab, Cyclophosphamide, Vincristine
1 $667.00
78968 Leukemia 1.0 ML Male
Clopidogrel, Rituximab, Cyclophosphamide, Vincristine
1 $667.00
78957 Leukemia 1.0 ML Male
Clopidogrel, Rituximab, Cyclophosphamide, Vincristine
1 $667.00
78958 Leukemia 1.0 ML Male
Clopidogrel, Rituximab, Cyclophosphamide, Vincristine
1 $667.00

Leukemia Plasma | High-Quality Human Plasma from Leukemia Donors

Leukemia Plasma is collected from donors clinically diagnosed with leukemia and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on circulating tumor DNA (ctDNA), cytokines, and metabolic markers to better understand leukemia pathophysiology.

Product Features

  • Research Use Only (RUO)
  • Plasma collected from clinically confirmed leukemia donors
  • Processed within one day of collection
  • IRB-approved protocols and informed consent
  • Custom aliquot volumes available upon request

De-identified Donor Data

  • Verified leukemia diagnosis
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Donor-reported medications, allergies, and comorbidities
  • Additional leukemia-specific metadata available

Applications

  • Biomarker discovery and validation
  • Cytokine and inflammation profiling
  • Metabolomics and proteomics studies
  • Therapeutic response research

Compliance and Quality Assurance

  • IRB-approved and HIPAA-compliant protocols
  • Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
  • Documentation support available for regulatory review

Ordering and Customization

Leukemia plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.

Protocols & Documentation

  • Plasma Isolation

    Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Plasma

Frequently Asked Questions

Showing 25–31 of 31 results

Do plasma samples come with clinical information (autoantibody status, HbA1c values, IHC results, stage information, genetic mutation data)?

1 Answer

YES – Comprehensive medical records are available and may contain information regarding autoantibody status.

YES – Sanguine offers both inventory for select conditions, as well as, prospective collection. For inventory visit https://sanguinebio.com/products/plasma/?pro_inventory=inventory.

We never thaw our plasma samples before shipping.

Our standard aliquot size for plasma is 1 mL but we have bulk plasma (50 to 150 mL) available for select conditions. https://sanguinebio.com/product/human-bulk-plasma/

YES – Sanguine bio provides “age-matched healthy controls” and longitudinal studies capabilities.

YES – custom age specifications available – The “Specify I/E Criteria” service allows you to define specific age ranges for donor selection.

Age ranges available – Donor metadata includes age specifications, and you can specify inclusion/exclusion criteria. For pediatric samples specifically, contact learnmore@sanguinebio.com.

1 2 3
×

Ask a Question

Need a custom Plasma cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information